StockCall Early Morning Insight into Covidien, Becton, Dickinson and Co., Stryker, MAKO Surgical, and Align Technology

Thu Apr 4, 2013 8:00am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

LONDON,  April 4, 2013  /PRNewswire/ --

Markets responded negatively to the recently released private job data. The Dow
Jones ended its latest session at 14,550.35, down 0.76 percent while NASDAQ was
down 1.11 percent to close at 3,218.60. Similarly, S&P also finished on a
negative note at 1,553.69, down 1.05 percent. Our research team took a look at
Healthcare sector which includes major companies like Covidien plc (NYSE: COV),
Becton, Dickinson and Co. (NYSE: BDX), Stryker Corp.(NYSE: SYK), MAKO Surgical
Corp. (NASDAQ: MAKO) and Align Technology Inc. (NASDAQ: ALGN). StockCall has
issued technical analysis and charting reports on COV, BDX, SYK, MAKO, and ALGN.
Download these free reports now at

In-line with the downward movement shown by broad market indices, Covidien plc's
stock finished 0.32 percent lower at  $67.79, with volume down from daily
average of 1.89 million to 1.87 million. The stock is up so far in 2013 with its
year-to-date gain at 20.39 percent. However, the stock currently shows a bullish
trend which is further confirmed by the stock's MACD chart. Covidien has its
first support level at  $65.50. Download the free research on COV today by
registering at

Becton, Dickinson and Co. traded in the range of  $95.97  and  $97.14  in its
latest trading session. Its volume stood at 1.76 million shares, up from its
average daily volume of 1.17 million. Becton, Dickinson and Co closed
Wednesday's session at  $96.41, down 0.18 percent. The stock is currently
trading above its short-term moving average price of  $96.3, showing a bullish
trend. In the coming sessions, Becton, Dickinson and Co. is expected to go as
high as  $96.95, while its first support level is at  $95.54. It has appreciated
24.66 percent on a YTD basis. Sign up and have access to our free report on BDX

Stryker Corp. is currently in a bullish mode despite the stock ending its
previous trading session at  $65.25, down 0.47 percent. The stock traded in the
range of  $64.80  and  $65.64  during yesterday's session. Its first support
level is at  $64.66  and upon breaching this support price the stock may go down
to  $62.23  level. On the upside, Stryker's stock may touch  $66.91  level. The
stock has traded in the range of  $49.43  and  $66.92  in the past 52 weeks and
it grew by 17.61 percent during the same time period. On a Year-to-Date basis,
the stock is up 19.83 percent.Sign up and read the complimentary report on SYK

MAKO Surgical Corp. extended its 52 weeks losses to 75.09 percent by closing its
previous trading session 1.04 percent lower. The stock closed at  $10.50, with
trading volume of 934,273 shares on Wednesday. It is down 13.15 percent on a YTD
basis. MAKO is currently in a bearish mode and is expected to go up to  $11.02 
in the coming trading sessions. Its next resistance level is at  $11.46. On the
downside, it is expected to face its first support level at  $10.20. The company
traded in the range of  $10.29  and  $43.06  in the past 52 weeks. The free
report on MAKO can be downloaded by signing up now at

Align Technology Inc. is currently trading marginally above its 20-day and
50-day moving average price and is in a neutral mode. It also ended its
yesterday's trading session 2.83 percent lower at  $30.95, further confirming
the trend. Align Technology exchanged 2.16 million shares during Wednesday's
session. The stock has outperformed the broader markets and has gained 14.33
percent so far this year. Free report on ALGN can be accessed by registering at

About is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at   


Contact Person: William T. Knight, Email: , Contact Number:
+1-(646)-396-9857 (9:00 am EST - 01:30 pm EST)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.